Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →
← Back to NAICS Codes
NAICS Code· 325412

NAICS 325412: Pharmaceutical Preparation Manufacturing

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--Show more

NAICS 325412 – Pharmaceutical Preparation Manufacturing encompasses the formulation, production, and packaging of finished pharmaceutical products, including sterile injectables, oral solids, topical creams, and other dosage forms intended for human or veterinary use. This sector involves complex manufacturing processes governed by cGMP standards, requiring validated equipment, rigorous quality control, and strict environmental controls to ensure product safety and efficacy.

207
Active Contracts
$15.3B
Total Obligations (12mo)
13.1K
Awarded Contracts (12mo)
342
Contractors Awarded (12mo)
1
Median Bidders per Award
-28.2%
YoY Growth

Contract Opportunities

Active solicitations and awarded contracts classified under NAICS 325412Pharmaceutical Preparation Manufacturing.

Dotted
NAICS 325412 FAQ

Frequently Asked Questions

NAICS code 325412 covers Pharmaceutical Preparation Manufacturing. This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--

Recently Posted in Pharmaceutical Preparation Manufacturing

NAICS: 325412
Awarded
DIBBS
AMOXICILLIN TABLETS
Solicitation # SPE2DP-26-T-4411
Amoxicillin Tablets USP 250 mg in blister packs of three tablets per unit, identified by NDC 00093-2268-01, are procured under solicitation SPE2DP-26-T-4411 with a required delivery of five days FOB destination. The contract specifies a total quantity of two blister trays (BT), each containing three units, for a total of six units, with zero variance allowed in quantity. The product must comply with strict packaging and marking standards per Medical Marking Standard No. 1, superseding MIL-STD-129, and must be packed in sealed unit containers that protect against damage, with shipping containers suitable for commercial carrier transport at the lowest rate. Shelf life is fixed at 24 months with no extensions permitted, in accordance with Type I (Code M) requirements. The item must be labeled and marked exactly as specified, and all packaging must conform to MIL-STD-2073-1E. The supplier must be either TEVA Pharmaceuticals USA, Inc. or Cardinal Health 200, LLC, and the product must meet all technical and quality standards referenced in the DLA Master List of Technical and Quality Requirements. Inspection and acceptance occur at the destination, and delivery is to Fort Lewis, WA, with the contracting office located under the Department of Defense’s Medical Supply Chain. The solicitation was posted on August 2, 2026, with responses due by August 10, 2026, and the NAICS code is 325412 for pharmaceutical preparation manufacturing.
Defense Logistics Agency

POSTED

1 day ago

DEADLINE

N/A
View Details

Win Contracts in Pharmaceutical Preparation Manufacturing

Get AI-powered intelligence on NAICS 325412 procurement

Real-time contract opportunities for NAICS 325412 (Pharmaceutical Preparation Manufacturing)

AI-powered matching based on your business capabilities and past performance

Competitive analysis of contractors winning awards in this industry

Automated alerts when new opportunities are posted

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS